These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8255496

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intravenous immunoglobulin versus plasma exchange in Guillain-Barré syndrome.
    Ng KK, Howard RS, Hirsch NP, Miller DH.
    Neurology; 1993 Dec; 43(12):2729; author reply 2730-1. PubMed ID: 8255495
    [No Abstract] [Full Text] [Related]

  • 3. Intravenous IgG in Guillain-Barré syndrome.
    Hughes RA.
    BMJ; 1996 Aug 17; 313(7054):376-7. PubMed ID: 8761208
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome.
    Kleyweg RP, van der Meché FG, Schmitz PI.
    Transfus Sci; 1994 Dec 17; 15(4):389-92. PubMed ID: 10172508
    [No Abstract] [Full Text] [Related]

  • 6. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously.
    van der Meché FG.
    J Neurol Neurosurg Psychiatry; 1994 Nov 17; 57 Suppl(Suppl):33-4. PubMed ID: 7964849
    [No Abstract] [Full Text] [Related]

  • 7. Second response to immunoglobulin in recurrent Guillain-Barré syndrome.
    Nagappan R, Barker J.
    N Z Med J; 1998 Nov 13; 111(1077):433-4. PubMed ID: 9861925
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Intravenous immunoglobulins in Guillain-Barré syndrome].
    Hidou M, Olivier J, Vivant JF.
    Ann Fr Anesth Reanim; 1992 Nov 13; 11(1):115. PubMed ID: 1443803
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changing views of Guillain-Barré syndrome.
    Asbury AK, McKhann GM.
    Ann Neurol; 1997 Mar 13; 41(3):287-8. PubMed ID: 9066348
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk factors for treatment related clinical fluctuations in Guillain-Barré syndrome.
    Rees JH.
    J Neurol Neurosurg Psychiatry; 1998 Feb 13; 64(2):148-9. PubMed ID: 9489520
    [No Abstract] [Full Text] [Related]

  • 18. Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.
    Kleyweg RP, van der Meché FG.
    J Neurol Neurosurg Psychiatry; 1991 Nov 13; 54(11):957-60. PubMed ID: 1800666
    [Abstract] [Full Text] [Related]

  • 19. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome].
    Hidou M, Olivier J, Vivant JF.
    Rev Neurol (Paris); 1992 Nov 13; 148(11):706-8. PubMed ID: 1303562
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.